SEC Form 4 Reporting Owner · CIK 0001545672
Adimab, LLC
10%+ at Invivyd Inc
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
3
Companies
1
Filing Activity
2024-01-22
first filed 2021-08-12
Trading record
Open-market buys
—
0 filings
Open-market sales
−$19.8M
1 filing
Sales under a 10b5-1 plan
0%
0 of 1 sale filing
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| IVVDInvivyd Insider trading | 10%+ | 3 | — | 5,000,000 | −5,000,000 | 21,687,906 2024-01-22 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.
Also files as
13D/G Beneficial owner of 5% or more · 1 open stake
| Company | Schedule | % of class | Filed |
|---|---|---|---|
| Invivyd | 13D | 7.3% | 2025-12-29 |